Literature DB >> 27410908

In situ CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY VISCERAL LEISHMANIASIS.

Claudio Nazaretian Rossi1, Thaise Yumie Tomokane2, Luis Fábio da Silva Batista3, Mary Marcondes4, Carlos Eduardo Larsson1, Márcia Dalastra Laurenti2.   

Abstract

Thirty-eight dogs naturally affected by visceral leishmaniasis were recruited in Araçatuba, São Paulo State, Brazil - an endemic area for visceral leishmaniasis. The animals were distributed into one of two groups, according to their clinical and laboratory features, as either symptomatic or asymptomatic dogs. Correlations between clinical features and inflammatory patterns, cellular immune responses, and parasitism in the macroscopically uninjured skin of the ear were investigated. Histological skin patterns were similar in both groups, and were generally characterized by a mild to intense inflammatory infiltrate in the dermis, mainly consisting of mononuclear cells. There was no difference in the number of parasites in the skin (amastigotes/mm²) between the two groups. Concerning the characterization of the cellular immune response, the number of positive inducible nitric oxide synthase (iNOS+) cells was higher in the dermis of symptomatic than in asymptomatic dogs (p = 0.0368). A positive correlation between parasite density and macrophages density (p = 0.031), CD4+ T-cells (p = 0.015), and CD8+ T-cells (p = 0.023) was observed. Furthermore, a positive correlation between density of iNOS+ cells and CD3+ T-cells (p = 0.005), CD4+ T-cells (p = 0.001), and CD8+ T-cells (p = 0.0001) was also found. The results showed the existence of a non-specific chronic inflammatory infiltrate in the dermis of dogs affected by visceral leishmaniasis, characterized by the presence of activated macrophages and T-lymphocytes, associated to cutaneous parasitism, independent of clinical status.

Entities:  

Mesh:

Year:  2016        PMID: 27410908      PMCID: PMC4964317          DOI: 10.1590/S1678-9946201658048

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  35 in total

1.  Epidermal immunocompetence in canine leishmaniasis.

Authors:  D Fondevila; M Vilafranca; L Ferrer
Journal:  Vet Immunol Immunopathol       Date:  1997-05       Impact factor: 2.046

2.  Histopathological and parasitological investigations of ear healthy skin of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi.

Authors:  Maria Marta Figueiredo; Eliane Perlatto Moura; Miriam Maria Costa; Vitor Marcio Ribeiro; Marilene Suzan Michalick; Washington Luiz Tafuri; Wagner Luiz Tafuri
Journal:  Histol Histopathol       Date:  2010-07       Impact factor: 2.303

3.  Qualitative and quantitative immunohistochemical evaluation of iNOS expression in the spleen of dogs naturally infected with Leishmania chagasi.

Authors:  Fernando Rocha dos Santos; Paula Melo Abreu Vieira; Rodrigo Correa-Oliveira; Rodolfo Cordeiro Giunchetti; Claudia Martins Carneiro; Alexandre Barbosa Reis; Luiz Cosme Cotta Malaquias
Journal:  Parasitol Res       Date:  2010-12-29       Impact factor: 2.289

4.  Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol.

Authors:  Sonia Miranda; Susanna Martorell; Manuela Costa; Lluis Ferrer; Antonio Ramis
Journal:  Vet Parasitol       Date:  2006-11-15       Impact factor: 2.738

5.  Evaluation of killing, superoxide anion and nitric oxide production by Leishmania infantum-infected dog monocytes.

Authors:  M A Panaro; S Lisi; V Mitolo; A Acquafredda; A Fasanella; M G Carelli; O Brandonisio
Journal:  Cytobios       Date:  1998

6.  A possible mechanism in the pathogenesis of cutaneous lesions in canine leishmaniasis.

Authors:  N Prats; L Ferrer
Journal:  Vet Rec       Date:  1995-07-22       Impact factor: 2.695

7.  Identification of Leishmania (Leishmania) chagasi isolated from healthy skin of symptomatic and asymptomatic dogs seropositive for leishmaniasis in the municipality of Rio de Janeiro, Brazil.

Authors:  Maria de Fátima Madeira; Armando de Oliveira Schubach; Tânia Maria Pacheco Schubach; Cristianni Antunes Leal; Mauro Célio de Almeida Marzochi
Journal:  Braz J Infect Dis       Date:  2005-05-09       Impact factor: 1.949

8.  Inducible nitric oxide synthase expression in Leishmania-infected dog macrophages.

Authors:  M Sisto; O Brandonisio; M A Panaro; A Acquafredda; D Leogrande; A Fasanella; T Trotta; L Fumarola; V Mitolo
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2001-10       Impact factor: 2.268

Review 9.  Systemic and compartmentalized immune response in canine visceral leishmaniasis.

Authors:  Alexandre Barbosa Reis; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Rodolfo Cordeiro Giunchetti; Cláudia Martins Carneiro; Wilson Mayrink; Washington Luiz Tafuri; Rodrigo Corrêa-Oliveira
Journal:  Vet Immunol Immunopathol       Date:  2008-10-17       Impact factor: 2.046

10.  Dog culling and replacement in an area endemic for visceral leishmaniasis in Brazil.

Authors:  Cáris Maroni Nunes; Valéria Marçal Félix de Lima; Henrique Borges de Paula; Silvia Helena Venturoli Perri; Andréa Maria de Andrade; Francisca Elda Ferreira Dias; Marcelo Nascimento Burattini
Journal:  Vet Parasitol       Date:  2008-01-17       Impact factor: 2.738

View more
  1 in total

Review 1.  An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy.

Authors:  Ana Alice Maia Gonçalves; Jaqueline Costa Leite; Lucilene Aparecida Resende; Reysla Maria da Silveira Mariano; Patricia Silveira; Otoni Alves de Oliveira Melo-Júnior; Helen Silva Ribeiro; Diana Souza de Oliveira; Diogo Fonseca Soares; Thaiza Aline Pereira Santos; Alexandre Ferreira Marques; Alexsandro Sobreira Galdino; Olindo Assis Martins-Filho; Walderez Ornelas Dutra; Denise da Silveira-Lemos; Rodolfo Cordeiro Giunchetti
Journal:  Front Cell Infect Microbiol       Date:  2019-12-18       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.